Accretion Nutraveda Limited is a nutraceutical and wellness-focused company engaged in the manufacturing and marketing of health supplements, herbal formulations, and functional nutrition products. The company earns revenue through B2B and B2C sales, supplying branded and contract-manufactured products. Its offerings are used for daily nutrition, immunity support, lifestyle health management, and preventive healthcare, catering to both domestic and export markets.

Key Clients and Manufacturing Facilities

The company caters to nutraceutical brands, wellness companies, distributors, and institutional buyers across India. Accretion Nutraveda operates its manufacturing facility in India, equipped with blending, formulation, packaging, and quality-testing infrastructure. The facility follows FSSAI and GMP-compliant processes, ensuring consistency, safety, and scalability. The integrated setup enables faster turnaround, controlled costs, and efficient order execution.

Product Portfolio and Order Book Execution

The product portfolio includes capsules, tablets, powders, syrups, and herbal supplements, covering immunity, digestion, metabolism, and general wellness. These products typically fall in the consumable and repeat-purchase category, supporting long client product life cycles. The order book is mainly short-to-medium tenure, executed through in-house manufacturing, allowing timely delivery, flexible batch sizes, and efficient capacity utilisation.

Mergers, Capex, and Expansion Plans

As per the RHP, the company has no ongoing merger or acquisition. The IPO proceeds are proposed to be utilised for capital expenditure, working capital requirements, and strengthening manufacturing capacity. Planned investments focus on equipment upgrades, product development, and operational scale-up, aimed at improving efficiency, expanding product offerings, and supporting future revenue growth.

Employees and Banker Details

As of Sep 30, 2025, the company had 18 full time employees. The Banker to the Company is HDFC Bank Limited.

MANAGEMENT & GROWTH VISION

The management team focuses on building a science-backed, scalable nutraceutical platform. Near-term growth aims include capacity expansion, wider product range, and deeper domestic penetration. Long-term targets involve brand-led growth, export market expansion, and value-added formulations. Funding for capex and expansion will be arranged through IPO proceeds, internal accruals, and efficient working capital management, while maintaining a prudent balance sheet.

INDUSTRY OVERVIEW

The company operates in the nutraceutical and dietary supplements industry, one of the fastest-growing health segments.

• Indian nutraceutical market size: ~₹60,000 crore
• Expected CAGR (India): ~15–18%
• Global nutraceutical market size: ~USD 450 billion
• Global growth rate: ~8–9% CAGR

Growth is driven by rising health awareness, preventive healthcare demand, ageing population, and lifestyle-related diseases. India is emerging as a manufacturing and formulation hub, while global leaders include Amway, Herbalife, and Nestlé Health Science.

KEY RISK FACTORS

1. Regulatory Compliance Risk
   The business is highly regulated under FSSAI and other health laws. Any non-compliance or change in regulations may impact product approvals, timelines, or operational costs.
2. Dependence on Key Raw Materials
   The company relies on specific herbal and nutritional ingredients. Price volatility or supply disruptions may affect margins and production schedules.
3. High Industry Competition
   The nutraceutical industry is fragmented and competitive, with both domestic and global players, which may pressure pricing and market share.
4. Limited Brand Visibility
   A significant portion of revenue comes from contract manufacturing, limiting direct brand recall and increasing dependence on third-party clients.
5. Working Capital Intensive Operations
   Inventory holding, receivables, and production cycles require continuous working capital, which may impact cash flows during rapid growth phases.
6. Consumer Preference Changes
   Shifts in consumer trends, formulation preferences, or health awareness may affect demand for existing product categories.

KEY STRENGTHS, MOAT & OPPORTUNITIES

1. Integrated Manufacturing Capability
   End-to-end in-house manufacturing ensures quality control, cost efficiency, and faster execution, creating a strong operational moat.
2. Wide Product Portfolio
   Presence across multiple dosage forms and wellness categories reduces dependence on a single product line.
3. High-Growth Industry Exposure
   Operating in a fast-growing nutraceutical market provides long-term structural growth opportunities.
4. Scalable Business Model
   The asset-light expansion approach and modular manufacturing enable scalable capacity growth with controlled capital costs.
5. Growing Preventive Healthcare Demand
   Rising focus on immunity, fitness, and lifestyle health creates repeat demand and long-term customer stickiness.
6. Export and Private Label Opportunity
   Increasing demand for Indian-manufactured nutraceuticals globally offers expansion into export and private-label segments.